Research Article
RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma
Figure 5
BAY 11-7082 (1 mg/kg) mitigates the antitumor effects of RSL3 (100 mg/kg) in a U87 xenograft model. (a) Representative images of tumors obtained from different groups at the termination of the xenograft assay. (b) Tumor weights from B-NDG mice injected with U87 cells and treated with different conditions. (c) Tumor volume growth curves of B-NDG mice in different treatment groups. Data are represented as the . .
(a) |
(b) |
(c) |